Cross-sectional study evaluates responsiveness of NAIL-Q in nail conditions, suggesting its effectiveness in measuring patient experiences.
The NAIL-Q demonstrated sufficient evidence of responsiveness in patients undergoing treatment for nail psoriasis, onychomycosis, brittle nails, or retronychia.
No takes yet. Share an insight, caveat, or question.
Forman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: